The role that potassium channels play in human T lymphocyte activation has been investigated by using specific potassium channel probes. Charybdotoxin (ChTX), a blocker of small conductance Ca 2 +-activated potassium channels (Pc,c,) and voltage-gated potassium channels (PK,v) that are present in human T cells, inhibits the activation of these cells. ChTX blocks T cell activation induced by signals (e.g., anti-CD2, anti-CD3, ionomycin) that elicit a rise in intracellular calcium ([Ca2+]i) by preventing the elevation of [Ca2+]i in a dose-dependent manner. However, ChTX has no effect on the activation pathways (e.g., anti-CD28, interleukin 2 [IL-2]) that are independent of a rise in [Ca2+]i. In the former case, both proliferative response and lymphokine production (Ib2 and interferon 3') are inhibited by ChTX. The inhibitory effect of ChTX can be demonstrated when added simultaneously, or up to 4 h after the addition of the stimulants. Since ChTX inhibits both PK,C~ and Pg.v. we investigated which channel is responsible for these immunosuppressive effects with the use of two other peptides, noxiustoxin (NxTX) and margatoxin (MgTX), which are specific for Pg, v. Theses studies demonstrate that, similar to ChTX, both NxTX and MgTX inhibit lymphokine production and the rise in [Ca2+]i. Taken together, these data provide evidence that blockade of PK,V affects the Ca2+-dependent pathways involved in T lymphocyte proliferation and lymphokine production by diminishing the rise in [Ca2+]i that occurs upon T cell activation.
T
he activation of T lymphocytes via antigen receptor is associated with phosphotidylinositol turnover and an increase in intracellular Ca 2+ ([Ca 2+ ]i) 1. Although part of this rise in [Ca2+] i appears to depend upon Ca 2+ influx, the precise mechanism responsible for elevation of [Ca2+]i remains to be determined (1) . In addition to Ca 2+ influx, T cell activation results in enhanced K § efflux. The predominant K + channel in human T lymphocytes is a voltage-gated channel (Pz.v) (2, 3) that has properties similar to a delayed rectifier K + channel of nerve cells which has been cloned (4) (5) (6) (7) (8) . Human T cells also possess a variety of small conductance Ca 2 +-activated K + channels (PK,c,) that have recently 1 Abbreviations used in this paper: ol-DaTX, o~-dendrotoxin; [Ca 2 + ]i, intracellular Ca 2+ concentration; ChTX, charybdotoxin; 4-AP, 4-aminopyridine; IbTX, iberiotoxin; InsP3, Inositol-l,4,5-triphosphate; MgTX, margatoxin; NxTX, noxiustoxin; PK,ca, Ca2+-activated potassium channd; Pg,v, vohage-gated potassium channel; TEA, tetraethylammonium. been characterized (9) . A link between the rise in [Ca2+] i and the function of these K + channels is not completely understood.
The rise in [Ca2+]i via receptor-operated channels or second messenger pathways is dependent on membrane potential. Lymphocyte membrane depolarization has been shown to result in an inhibition of mitogen-activated Ca 2+ uptake (10) , as well as anti-CD3-and anti-CD2-induced increase in [Ca2+] i in human T lymphocytes (11, 12) or Jurkat cells (13) . [Ca 2+ ]i elevation induced by thapsigargin, an inhibitor of the endoplasmic reticulum Ca 2 +-ATPase, is also prevented when lymphocytes are depolarized (10, 14) .
Evidence for the involvement of K + channels in T cell activation comes from experiments demonstrating that agents known to block K + channels inhibit this process (10) . PHAstimulated human T cell activation as measured by IL-2 production, proliferation, and protein synthesis was shown to be inhibited by the nonselective K § channel blockers, tetraethylammonium (TEA) and 4-aminopyridine (4-AP) (15) . TEA was also reported to inhibit elevation in [Ca2+]i (16) .
However, the concentrations of both TEA and 4-AP necessary to cause these effects are very high (mM range), and therefore their effects on T cell activation could be nonspecific (17) . Charybdotoxin (ChTX), a 37-amino acid peptide isolated from venom of the scorpion Leiurus quinquestriatus var. hebraeus (18) , blocks with high affnity both P~r in human lymphocytes (9) and PK,v in T lymphocytes from several species (19) . The effect of ChTX on human lymphocyte activation has been reported by several groups, but with conflicting results. For example, Price et al. (20) and Bono et al. (21) demonstrated that ChTX inhibited PHA-stimulated T cell proliferation and Ib2 production. Gelfand and Or (22) , however, reported that ChTX inhibited cell membrane hyperpolarization in T lymphocytes stimulated by PHA, but had no effect on the proliferative response. Thus, the putative role of K + channels in controlling T cell activation remains unclear.
To address this issue, the effects of a variety of peptidyl K + channel inhibitors on different activation parameters in human T cells have been investigated. In this study, we demonstrate that ChTX inhibits T cell activation, as measured by either proliferation or lymphokine production, when triggered by pathways associated with a rise in [Ca~+] i. In this respect, the action of ChTX is remarkably similar to that of cyclosporin A and FK-506 (23) . Since ChTX inhibits both PK,c, and PK,v, the effects of several selective Pi~,v blockers, such as noxiustoxin (NxTX) (5, 9) and the recently isolated peptide margatoxin (MgTX) (9, 24) , were also investigated on T cell activation to discern which channel is responsible for the profile obtained with ChTX. With the use of these peptidyl inhibitors, we conclude that blockade of Pz,v is sufficient to inhibit human T cell activation. This PK,v inhibition appears to cause membrane depolarization (9) which in turn blocks the rise in [Ca2+]i. These results confirm and extend the data of others by identifying PK,V as the relevant ion channel for the in vitro immunosuppressive effects of ChTX.
Materials and Methods
Reagents. ChTX was purified to homogeneity from the scorpion L. quinquestriatus vat. hebraeus obtained from Alomone Laboratories (Jerusalem, Israel) (18) . Synthetic NxTX was generously provided by Dr. R. Nutt (Merck Research Laboratories, West Point, PA). Iberiotoxin (IbTX) was isolated from Buthus tamulus venom as described (25) . c~-Dendrotoxin (cr was a gift of Dr. M. Blaustein (University of Maryland, Baltimore, MD). MgTX was isolated from venom of the scorpion Centruroides margaritatus (24) .
All peptides were stored lyophylized at -70~ Before the experiments, the peptides were reconstituted to 10/xM in Tris buffer (20 mM Tris/HC1, 100 mM NaC1, pH 7.4) with 0.1% BSA also present. FK-506 was isolated from Streptomyces tsukubaensis by Dr.
R. Borris (Merck Research Laboratories). FK-506 was dissolved at 1 mg/mL in ethanol and stored at -70~ PMA (Sigma Chemical Co., St. Louis, MO) and ionomycin (Calbiochem Corp., San Diego, CA) were dissolved at 10/~g/ml and I mg/ml, respectively, in dimethyl sulfoxide and stored at -70~ Recombinant human Ib2 was obtained from Amgen Biologicals (Thousand Oaks, CA). OKT3 (anti-CD3) mAb was obtained from Ortho Diagnostic Systems (Raritan, NJ). Affinity-purified rabbit anti-mouse IgG was obtained from Cappel (Organon Teknika Corp., West Chester, PA) Anti-CD28 (mAbs 9.3) was a gift from Drs. J. A. Ledbetter (Genetic Systems, Seattle, WA) and C. June (Naval Medical Research Institute, Bethesda, MD). Anti-CD2 mAbs Tll.2 and Tll.3 were gifts from Dr. E. Reinhertz (Harvard Medical School, Boston, MA)
CellPreparations. PBMC were isolated from heparinized blood samples of normal donors using lymphocyte separation medium (LSM; Litton Bionetics, Kensington, MD) density gradient centrifugation followed by lysis of erythrocytes with ACK lysing buffer (Gibco, Grand Island, NY). Highly purified T lymphocytes were further isolated by nylon wool as described previously (23) .
Proliferation Assays. Highly purified T lymphocytes were cultured in triplicate samples in flat-bottomed, 96-well microtiter plates (Costar, Cambridge, MA) at 2 x 105 cells per well in complete medium consisting of RPMI 1640 medium (Gibco) supplemented with 10% heat-inactivated FCS (Hyclone Laboratories, Logan, UT), 2 mM t-glutamine, 100/xM nonessential amino adds, 20/zM 2-ME, 100 U/ml penicillin, and 100/~g/ml streptomycin. The cultures were stimulated with anti-CD2 (Tll.2 + Tll.3), anti-CD3 (OKT3), anti-CD28 (9.3), or ionomycin, with or without PMA. Either ChTX, NxTX, c~-DaTX, IbTX, or FK-506 at indicated concentrations, was added at the beginning of the incubation. The cultures were incubated for 2 d at 37~ in a 5% CO2 atmosphere, and T cell proliferation was measured by addition of [3H]thymidine (6.7 Ci/mmol, New England Nuclear, Boston, MA) to each culture (2/~Ci per well), 4 h before harvesting. Cultures were harvested on glass fiber filters using a cell harvester (Skatron, Inc., Sterling, VA). Radioactivity was measured using the Betaplate Liquid Scintillation System (model 1205; Pharmacia LKB Nuclear Microtomy Inc., Gaithersburg, MD). All data are shown as the means of triplicate cultures.
Mixed Lymphocyte Reaction. PBMC were cultured in triplicate samples in round-bottomed, 96-well microtiter plates (Costar) at 2.5 x 10 s cells per well in complete media as described for the proliferation assay. Equal amounts of irradiated mononuclear cells from a second individual were added to the cultures as stimulator cells. FK-506, ChTX, NxTX, c~-DaTX, and IbTX, at indicated concentrations, were added at the beginning of the cultures. The cultures were incubated at 37~ in a 5% CO2 atmosphere. T cell proliferation was measured as described for the proliferation assay.
12sI-ChTX Binding Assay. To characterize the interaction of NxTX, c~-DaTX, and IbTX with the human T cells used in this study, we tested the ability of these peptides to compete for the binding of 12sI-ChTX to the preparation as previously described (26) . Briefly, monocyte-depleted, E-rosetted lymphocytes (2.5 x 106 cells/ml, 0.4 ml per tube) were incubated in 12 x 75-mm polystyrene tubes with 5 pM nsI-ChTX in the absence or presence of increasing concentrations of various toxins. The binding assay is carried out in isotonic sucrose medium containing 10 mM Hepes, 5 mM KC1, 5 mM NaC1, and 6 mM glucose, pH 7.4. The reaction mixtures were incubated for 1 h at room temperature on a rotary shaker. At the end of the incubation period, the samples were diluted with 4 ml of cold quench solution (200 mM NaC1, 20 mM Hepes, titrated to pH 8 with Tris-base) and faltered through glass microfiber filters (GF/C; Whatman Inc., Clifton, NJ) that had been presoaked in 0.6% polyethylenimine. Nonspecific binding was determined in the presence of 10 nM ChTX. Each data point represents the average of triplicate samples.
Measurement of lL2 and IFN-7 Production. Lymphocytes were cultured in triplicate wells of 96-well microtiter plates and stimulated with OKT3 or ionomycin and PMA. Supernatants were collected 4 or 24 h after the initiation of cultures. The Ib2 level in each supernatant was measured using the IL-2 ELISA assay system (Collaborative Research, Bedford, MA). IFN-3, was quantitated using a KIA assay system (Centocor, Philadelphia, PA).
Measurement of[Caa+]i. Most of the flow cytometric [Ca2+]i
determinations were performed as previously described (23) . Purified lymphocytes were washed with RPMI 1640 buffered with 10 mM Hepes, pH 7.4. The pellet was resuspended at 2 x 10 s cells/ml in RPMI-Hepes containing 1 #M indo-1 AM (Molecular Probes, Inc., Eugene, OK) and incubated 45 min at 37~ in the dark. The cells were then subjected to centrifugation, resuspended in the original volume of RPMI-Hepes and incubated an additional 45 min at 37~ in the dark. After centrifugation, the cells were resuspended in RPMI-Hepes at 2 x 106 cells/ml and maintained in the dark at room temperature until analysis. A FACS | Analyzer/Consort 30 equipped with a 55-megabyte hard disc/tape drive (Becton Dickinson Immunocytometry Systems, San Jose, CA) was adapted to measure intracellular Ca 2 § using indo-1. An increase in [Ca2+]i was detected with indo-1 as an increase in the ratio of a lower to a higher emission wavelength (405 nm/485 nm emission) which is proportional to the internal calcium level. Since no standardization curve was determined to correlate intracellular calcium concentration with indo-1 ratio, the data are expressed as relative [Ca2+]i. Indo-loaded lymphocytes were incubated with peptides at 37~ for 15 rain. OKT3 (10 ng/ml) was added and the [Ca2+]i response was monitored for 3-4 min, before rabbit anti-mouse IgG antibody (40 #g/ml) was added. In some experiments, ionomycin (125 ng/ml) was added and the [Ca2+]i response was measured. For the membrane depolarization experiments using high potassium buffers, the appropriate buffer was also used as sheath fluid. In more recent experiments, data from the FACS | Analyzer sensor head were collected as a continuous file into Consort 40/#VAX computer system via a FACS | Data Lister (Becton Dickinson). Mean [Ca2+l, time course data were displayed using KINPRO Software (Becton Dickinson & Co.).
Measurement of Inositol-1,4,5-Trisphosphate (InsPs).
Purified T lymphocytes were suspended at 2 x 107/ml in 0.5 ml of HBSS containing 20 mM Hepes (pH 7.4) and 0.1% FCS in microfuge tubes, and preincubated with OKT3 (1 #g/ml) at 4~ for 5 min.
All tubes were transferred to a 37~ waterbath and incubated for 2 min. Cells were then activated by adding rabbit anti-mouse IgG antibody (40/~g/ml). The reaction was terminated at the indicated times by adding 0.2 volumes of ice-cold 100% TCA solution. The concentration of InsP3 in each sample was quantified by using a radioreceptor assay kit (Dupont, Wilmington, DE). Results Table 1 suggest that ChTX produces the same pattern of inhibition as FKo506. Thus, ChTX inhibits proliferative responses induced by anti-CD3 + PMA or ionomycin + PMA, but had no effect on II~2 + PMA-induced proliferation. Therefore, ChTX only inhibits pathways that are associated with a rise in [Ca2+]t.
ChTX Only Inhibits T Lymphocyte Proliferation and
We next examined the effect of ChTX on IL-2 production using the distinct activation pathways previously described. Lymphocytes, preincubated with ChTX at 37~ for 15 rain, were stimulated with anti-CD3 + PMA or anti-CD28 + PMA, and supernatants were collected after 24 h for determination of II.-2. As shown in Fig. 1 , ChTX inhibits Ib2 production stimulated by anti-CD3 + PMA in a dosedependent manner, whereas I/_-2 production of lymphocytes stimulated by anti-CD28 + PMA is unaffected. T lymphocytes (10~/ml, 0.2 ml/well) were cultured in 96-wall plates. ChTX or FK-506 was added at a final concentration of 10 nM. Different stimulants were then added to the cultures as indicated. The final concentration of PMA was 1 ng/ml; anti-CD3, 10 ng/ml; Ionomycin, 250 ng/ml; IL-2, 10 U/ml; anti-CD28, 10 ng/ml; anti-CD2:T11.2, 84/~g/ml, and Tll.3, 56/tg/ml. The cultures were incubated for 2 d and [3H]thymidine incorporation determined. All data are shown as the means of triplicate cultures. SD for each data point is <5%. Table 2 indicate that ChTX preincubation did not inhibit the production of InsP3 in OKT3-stimulated T cells.
P~,v Is the Relevant Target for the Immunosuppressive Effects of ChTX. Since ChTX blocks both Pz.c, and PK.v in
human T cells (9), we wished to investigate whether blockade of one or both of these channels was necessary for the immunosuppressive effects observed with the peptide. NxTX and IbTX are peptides purified from other scorpion venoms which share 40 and 68% sequence homology with ChTX, respectively. NxTX inhibits only ChTX-sensitive Pz.v, but not PK.c, in human T lymphocytes (9). IbTX consists of a single 4.3-kD polypeptide chain and selectively inhibits the high conductance Pz.ca in smooth muscle. This peptide does not block ChTX-sensitive PK,ca or PK,V in lymphocytes (9, 26). ot-DaTX is a weak blocker of Pz,v in lymphocytes (26). As shown in Fig. 4 A, NxTX and a-DaTX inhibit the binding of t2sI-ChTX to Pz.v in lymphocytes, whereas IbTX has no effect. These results are consistent with previously reported data indicating that t~sI-ChTX binding is a monitor of PK,v in human T cells (26). The dose-response curves of ChTX, NxTX, oe-DaTX, and IbTX on anti-CD3 + PMA-induced proliferation are shown in Fig. 4 B. ChTX and NxTX inhibit this proliferative response with IC50 of 3 and 8 nM, respectively, whereas IbTX has no effect. The rank order of potency of these peptides in blocking T cell proliferation (Fig. 4 B) correlates well with their rank order in competing for the binding of 12sI-ChTX to PK,v in lymphocytes (Fig. 4 A) . These results further sup- port the notion that blockade of PK.v is sufficient to inhibit T cell activation. The difference in the absolute potencies of the peptides in the two assays is most likely due to the fact that binding experiments are carried out in low ionic strength buffer, whereas proliferation effects are monitored in physiological culture media (26) . We next tested the effect of ChTX and NxTX on a MLR in order to better understand if blockade of Pg.v can influence T cell function after activation by a more physiologically relevant stimuli. Using this protocol, we found that both ChTX and NxTX inhibit the MLR in a dose-dependent manner (Fig. 5) . The ICs0 for both agents are similar to those found in blocking anti-CD3 + PMA-induced proliferation (Fig, 4 B) . These results illustrate that PK,v is the relevant target for the immunosuppressive effect of ChTX.
Blockade of PK, v Inhibits Lymphokine Production.
We have previously demonstrated (Fig. 1) Figure 6 . Blockade of PK,V inhibits lymphokine production. T lymphocytes (10?/ml, 1 ml/we11) were cultured in each well of the 24-well plates. Compounds tested were added at a final concentration of 10 nM. lonomycin (250 ng/ml) and PMA (10 ng/ml) were then added to the cultures. Supernatants were collected from each culture 4 h later and IL.2 and IFN-3/levels were determined. Data are expressed as percent control. The IL-2 level in control was 450 U/ml. IFNw level in the control culture was 50 U/m1. All data are shown as the means of triplicate cuhures. SD for each data point is <5%. production stimulated by anti-CD3 + PMA. To determine whether other pathways that generate a rise in [Ca 2+]i are affected by PK.v inhibition, the effects of toxins on lymphokine production were investigated after T cell stimulation with ionomycin + PMA. For this experiment, larger numbers of cells per culture were used and supernatants were collected 4 h after the addition of the stimulus. ChTX, NxTX, c~-DaTX, and IbTX were each tested at 10 nM. ChTX and NxTX, but not o~-DaTX or IbTX inhibit II.-2 (Fig. 6 A) and IFN-3, (Fig. 6 B) production by ionomycin + PMA-stimulated lymphocytes. These results are consistent with those found in proliferation and binding assays. Whereas ol-DaTX is a weak inhibitor of binding, it had no effect on either proliferation or lymphokine production at a concentration of 10 nM.
The role of PK,V in lymphokine production was further supported by studying the newly isolated peptide MgTX. Electrophysiological data indicate that MgTX is a more potent inhibitor of the human T lymphocyte PK,V than either ChTX or NxTX, and it has no effect on the ChTX-sensitive PK,Ca of lymphocytes (9) . The effect of MgTX on IL-2 production of ionomycin + PMA-stimulated T lymphocytes was determined. As shown in Table 3 , MgTX inhibits IL-2 production of activated lymphocytes and, as predicted, appears to be more potent than ChTX.
NxTX and MgTX Inhibit Mitogen-induced Rise in [Ccl2+]i.
To further determine whether NxTX, o~-DaTX, IbTX, and MgTX would effect the rise of [Ca2+]i induced by anti-CD3 as previously demonstrated for ChTX, this parameter of T cell activation was monitored. As shown in Fig. 7 A, 100 nM NxTX blocks the increase in [Ca2+] i, as does ChTX, whereas 100 nM oe-DaTX has little or no effect. IbTX at 100 nM, which has no effect on T cell proliferation, also has no effect on the rise in [Ca2+]i (data not shown). Consistent with its potency in blocking PK.V and lymphokine production, MgTX is the most potent inhibitor of the rise in [Ca2+]i of all the toxins used in this study (Fig. 7 B) . These Table 3 . Lymphocytes (3 x 106/ml, 0.2 ml per well) were cultured in 96-well plates with various concentrations of ChTX or MgTX. Ionomycin (250 ng/ml) and PMA (1 ng/ml) were then added to the cultures. After 24-h incubation, supernatants were collected and IL-2 levels determined. All data are shown as the means of triplicate cultures. lution (80 raM), the cell membrane is depolarized (11) . Therefore, we examined the effect of changes in membrane potential on the rise in [CaZ+]i of lymphocytes activated by anti-CD3 in high K + medium. Fig. 8 shows that the [Ca z + ]i increase induced by anti-CD3 is inhibited when cells are suspended in high K + solutions. Inhibition of both the transient increase and the sustained plateau are similar in magnitude to those observed in the presence of a maximal concentration of ChTX. As expected, addition of ChTX in 80 mM K § does not have an additive effect (data not shown).
Effect of MgTX on IL-2 Production

Discussion
The results presented in this paper demonstrate that ChTX, an inhibitor of Pz.v and small conductance PK,Ca in human T cells, blocks the proliferative response and lymphokine production of T cells activated only by pathways that induce a rise in [Ca2+]i, such as those stimulated by anti-CD3, anti-CD2, or ionomycin + PMA. ChTX exerts its immunosuppressive effect in a specific manner since the block in II.-2 production can be bypassed if the cells are activated via the biochemically distinct CD28 pathway. Furthermore, the ability of ChTX to inhibit a MLR implies that a variety of antigenspecific responses may be susceptible to inhibition through this toxin-sensitive pathway. With respect to its selectivity for certain types of lymphocyte activation pathways, the immunosuppressive properties of ChTX are indistinguishable from those of FK-506 and cyclosporine. The sites of action of these immunosuppressants are distinct, however, since FK-506 and cyclosporine interfere with a cytosolic, Ca2+-associated signaling process, and do not have a direct inhibitory effect on the rise in [Ca2+]i (23) .
PK,v has been demonstrated to be the predominant K § channel in human T lymphocytes, and its gating properties, conductance, kinetics, and selectivity have been well characterized (2, 3). More recently, human lymphocyte PZ,Ca have also been identified and characterized (9) . The possible involvement of these K § channels in T cell activation has been addressed by different investigators. Early studies suggesting a role for PK,v were not conclusive because the high concentrations of the nonselective K § channel blockers TEA and 4-AP required to show inhibition of T cell proliferation may have interfered with cellular processes nonspecifically. Specific K § channel toxins have provided an important tool for investigating the role of K § channels in T cell activation. In this respect, previous studies have shown that PHA-induced proliferation was inhibited by ChTX, and that the inhibitory effect of ChTX was at the level of IL-2 production (20) .
Since ChTX inhibits both Pz.ca and Pz.v in human T lymphocytes, blockade of either one or both of these channels may be sufficient to interfere with T cell activation. This question was directly addressed pharmacologically by the use of peptides that are selective for Pz.v. Electrophysiological data have shown that NxTX and MgTX are selective inhibitors of PK,v in that they do not block Pz,c, in human T lymphocytes (9) . ot-DaTX is a less potent inhibitor of PK,v, whereas IbTX blocks neither PK,v nor PK,Ca. The rank order of potency of these peptides is identical in affecting each of the T cell parameters studied: (a) inhibition of 125I-ChTX binding to human T lymphocytes; (b) proliferation; (c) lymphokine production; and (d) interference with a rise in [CF + ]i. Therefore, it can be concluded that blockade of PK,v is the relevant target for inhibition of the phenomena investigated in this study.
The role of PK,C, in human T cells remains unclear. T cell activation by mitogen (27, 28) , anti-CD3 (13), or ionomycin (29) is accompanied by membrane hyperpolarization. Hyperpolarization has been suggested to be a consequence of the activation of Pz,c, secondary to the increase in [Ca2+]i, and ChTX was thought to exert its antiproliferative effect by inhibiting Pz,c, (27) . Results in this study, however, suggest that PK,V, through its ability to set resting potential of T lymphocytes, is the most relevant target for the action of the peptides. It is not known whether a selective inhibitor of PK,c, would have a similar spectrum of immunosuppressive activities as a PK,V blocker, since such pharmacological probes have not, as yet, been identified.
It is well known that a rise in [CF + ]i is a necessary step in the T cell activation cascade. Although it is generally agreed that the early phase of calcium elevation is associated with release of calcium from internal stores, calcium from external sources also contributes to the early phase of calcium elevation. Data obtained by us and others (30) show that in the presence of EGTA (to remove extracellular calcium), the early phase of calcium elevation induced by anti-CD3 was inhibited and subsequently, T cell activation measured by IL-2 RNA transcription (31) or proliferation (32) was also inhibited. These data indicate that a large portion of the early phase of calcium elevation comes from the extracellular source, and that blocking the early phase can lead to the inhibition of T cell activation. In this study we demonstrated that ChTX inhibits the early phase of Ca 2 + elevation. Whether ChTX inhibits calcium release or calcium influx, or both is not presently known. The current studies also do not allow us to address the role of intracellular Ca 2+ stores vs. influx in eliciting the rise in [Ca2+]i directly. Nevertheless, the observation that both the TCR-induced and ionomycin-mediated rise in [CaZ+] i are blocked by the toxins suggest that Pz,v is an important determinant in controlling T cell Ca z + homeostasis.
How does inhibition of PK,V affect the rise in [Ca2+]i? Depolarization of the T cell, whether mediated by blockade of PK,v or by incubation in high K § solution, is sufficient to inhibit the rise in [CaZ § Indeed, ChTX, NxTX, and MgTX have recently been shown to depolarize resting lymphocytes (9) . The observation that cellular depolarization inhibits the mitogen-induced elevation of [CaZ+]i has been made previously (10) (11) (12) (13) , but these earlier studies had not related their finding to blockade of PK,V. It is not clear why the effects of ionomycin are also inhibited by ChTX since the ionophore is electroneutral. It is possible that depolarization of the membrane potential by ChTX leads to inhibition of ionomycin-mediated release of intracellular CF +. That depolarization inhibits ionomycin-induced [Ca2+]i was reported earlier (29) . Perhaps an internal negative membrane potential drives influx of Ca 2+ into lymphocytes and de-polarization limits this process. If Ca 2 § normally cycles into and out of intracellular stores, limiting Ca 2+ influx, while allowing cellular Ca 2+ efflux to occur, will eventually decrease the amount of intracellular Ca 2 § supplies. In such a model, intracellular Ca 2+ stores would be in equilibrium with the resting potential, and depolarization would make this Ca 2+ pool unavailable for release after mitogen stimulation.
In conclusion, this investigation provides a mechanistic basis for the previously observed immunosuppressive effects of ChTX. We have confirmed and extended results indicating that ChTX inhibits T cell proliferation and lymphokine production when triggered through Ca2+-associated signal transduction pathways. Moreover, similar data have been obtained with PK,v selective peptides, suggesting that blockade of PK,v, because of its role in setting the resting potential in T lymphocytes, leads to inhibition of the activation-induced rise in [Ca2+] i. The precise mechanism by which changes in membrane potential result in alterations in Ca 2+ homeostasis remains to be determined. It will also be interesting to determine the relevance of PK,V as a target for inhibition of immune responsiveness in vivo.
